RecruitingNot Applicable

Assessment of ADC Values and Radiomics Characteristics With a MRI of the Prostate to Identify Tumor Lesions

Italy120 participantsStarted 2021-10-23

Plain-language summary

The goal of this observational study is to assess the chance to predict prostate cancer with the analysis of specific values found in images obtained from RMmp (multiparametric magnetic resonance imaging) of patients who went through the procedure at IRCCS Azienda Ospedaliero-Universitaria hospital in the city of Bologna from September 2015 to March 2021. The main question it aims to answer is: \- does the analysis of ADC values and radiomics values found in the RMmp images help with the detection of prostate cancer?

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Presence of one or more lesions classified as PI-RADSv2.1 ≥ 3 at a prostate RMmp at the IRCCS Azienda Ospedaliero-Universitaria in Bologna * Indication for eco-guided targeted biopsy by fusion technique integrated with systematic biopsy * Indication for radical prostatectomy * Participants aged 18 at the time of examination * Obtaining informed consent. Exclusion Criteria: * Impossibility of performing MRI (claustrophobic or obese participants etc.) or contraindications to the execution of MRI * Technically sub-optimal investigations for the presence of artifacts (hip prosthesis, movement of the endorectal probe, etc.)

What they're measuring

Distribution of ADC

Timeframe: From enrollment to the end of treatment at 4 years

Trial details

NCT IDNCT06774781

SponsorIRCCS Azienda Ospedaliero-Universitaria di Bologna

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-12-31

Contact for this trial

Caterina Gaudiano, MD

+39 0515142307 caterina.gaudiano@aosp.bo.it

View on ClinicalTrials.gov More Prostate Cancer (Adenocarcinoma) trials